⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4253721 | 0.79 | CA2 (0.30) | — | |
| SCHEMBL4301194 | 0.79 | CA2 (0.30) | — | |
| SCHEMBL466032 | 0.79 | CA2 (0.48) | — | |
| SCHEMBL28274488 | 0.79 | — | — | |
| SCHEMBL14955466 | 0.79 | — | — | |
| SCHEMBL4255402 | 0.79 | CA2 (0.33) | — | |
| SCHEMBL5139188 | 0.77 | CA2 (0.35) | — | |
| SCHEMBL28917048 | 0.77 | CA2 (0.52) | — | |
| SCHEMBL4250296 | 0.76 | CA2 (0.32) | — | |
| SCHEMBL21004029 | 0.76 | CA2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9643935-B2 | Process for preparing 4,6-BIS (aryloxy) pyrimidine derivatives | CHEMINOVA A/S (DK) | 2017-05-09 | — | — | US | claimed |
| US-20160137612-A1 | PROCESS FOR PREPARING 4,6-BIS (ARYLOXY) PYRIMIDINE DERIVATIVES | CHEMINOVA A/S (DK) | 2016-05-19 | — | — | US | claimed |
| EP-3004066-A1 | PROCESS FOR PREPARING 4,6-BIS(ARYLOXY)PYRIMIDINE DERIVATIVES | Cheminova A/S (DK) | 2016-04-13 | — | — | EP | claimed |
| WO-2014190997-A1 | PROCESS FOR PREPARING 4,6-BIS(ARYLOXY)PYRIMIDINE DERIVATIVES | CHEMINOVA A/S (DK) | 2014-12-04 | — | — | WO | claimed |
| US-20100063275-A1 | PROCESS FOR PREPARING 6-PHENOXYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVES | SYNGENTA LIMITED (GB) | 2010-03-11 | — | — | US | claimed |
| EP-2074104-A1 | PROCESS FOR PREPARING 6-PHEN0XYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVE | Syngenta Limited (GB) | 2009-07-01 | — | — | EP | claimed |
| WO-2008043977-A1 | PROCESS FOR PREPARING 6-PHEN0XYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVE | SYNGENTA LIMITED (GB) | 2008-04-17 | — | — | WO | claimed |
| EP-4373493-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH ENHANCED IMID ACTIVITY | Nurix Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-4370123-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY | Nurix Therapeutics, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| US-20240124475-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20240092766-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMA (US) | 2024-03-21 | — | — | US | disclosed |
| EP-4334303-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | Nurix Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4334302-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS, COMPRISING THE SAME, METHODS OF THEIR MAKING, AND METHODS OF THEIR USE | Nurix Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-1272322-C | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC (CA) | 2006-08-30 | — | — | CN | disclosed |
| WO-2006054182-A9 | PHOSPHOINDOLES AS HIV INHIBITORS | IDENIX CAYMAN LTD | 2006-08-17 | — | — | WO | disclosed |
| CN-1817864-A | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC (CA) | 2006-08-16 | — | — | CN | disclosed |
| WO-2006054182-A2 | PHOSPHOINDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| US-20060074054-A1 | Phospho-indoles as HIV inhibitors | IDENIX PHARMACEUTICALS LLC | 2006-04-06 | — | — | US | disclosed |
| CN-1608052-A | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC (CA) | 2005-04-20 | — | — | CN | disclosed |
| US-4973598-A | Substituted imidazolinones and imidazolinethiones | BAYER AKTIENGESELLSCHAFT (DE) | 1990-11-27 | — | — | US | disclosed |